Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
McKinsey
Colorcon
Covington
Chubb
McKesson
Mallinckrodt
Harvard Business School
Queensland Health

Generated: February 23, 2018

DrugPatentWatch Database Preview

PENTOBARBITAL SODIUM Drug Profile

« Back to Dashboard

When do Pentobarbital Sodium patents expire, and when can generic versions of Pentobarbital Sodium launch?

Pentobarbital Sodium is a drug marketed by Lannett, Vitarine, Whiteworth Town Plsn, Custopharm Inc, Elkins Sinn, Renaissance Ssa Llc, and Sagent Pharms. and is included in nine NDAs.

The generic ingredient in PENTOBARBITAL SODIUM is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.

US Patents and Regulatory Information for PENTOBARBITAL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett PENTOBARBITAL SODIUM pentobarbital sodium CAPSULE;ORAL 085937-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Renaissance Ssa Llc PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 206677-001 Nov 27, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Whiteworth Town Plsn PENTOBARBITAL SODIUM pentobarbital sodium CAPSULE;ORAL 083338-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sagent Pharms PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 206404-001 May 23, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett PENTOBARBITAL SODIUM pentobarbital sodium CAPSULE;ORAL 085915-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vitarine PENTOBARBITAL SODIUM pentobarbital sodium CAPSULE;ORAL 083284-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Elkins Sinn PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 083270-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Custopharm Inc PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 203619-001 Nov 13, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vitarine PENTOBARBITAL SODIUM pentobarbital sodium TABLET;ORAL 083285-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Queensland Health
US Department of Justice
Moodys
Cipla
Johnson and Johnson
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot